Article
Nov 12, 2025

Improving Biological Age with GLP-1 RAs: An Analysis of a Study 

This is a further dive into and expansion of a Journal Club video that I offered in September 2025 in response to a fascinating article related to the power of GLP-1 peptides to create positive epigenetic changes at the cellular level. 

The study, Semaglutide Slows Epigenetic Aging in People with HIV-associated lipohypertrophy: Evidence from a Randomized Controlled Trial, is in preprint and has not yet been peer-reviewed, but offers substantive evidence of semaglutide’s versatile effects on cellular pathways related to metabolism, inflammation, and the immune system. In particular, the study examines the use of semaglutide (a GLP-1 receptor agonist) to control or slow the epigenetic aging of people with HIV (PWH) and  associated lipohypertrophy, a common condition with this population of patients. 

Through the lens of “the emerging geroscience paradigm” (Kennedy,et al, 2014), the study authors suggest that HIV-associated lipohypertrophy (a condition characterized by excessive accumulation of visceral and ectopic adipose tissue) offers an opportunity to examine the impact of semaglutide on a cohort who represent the “accelerated-aging phenotype” and look at possible implications for GLP-1 RAs as agents that improve biological age.

I was drawn to this article because of its focus on the pleiotropic power of GLP-1 RAs, a topic that I’ve discussed in several Masterminds, focused on in my soon-to-be released weight loss course, and devoted an entire book to – The Quantum Power of GLP-1 Peptides (SSRP, 2025). As we know from the plethora of existing research, GLP-1 peptides such as Semaglutide decrease inflammation, improve metabolism, and support the immune system. The two-part question that the article prompted for me was this: if GLP-1 RAs can positively affect cellular metabolism, immune function, and inflammation, thereby altering the cellular environment, wouldn’t it make sense that they also have the potential to increase the healthspan – or lifespan – of the cell? And I think the answer, intuitively, is – absolutely.  

Members-Only Content

This article contains exclusive content for SSRP members. Join today to unlock the full article and gain access to our entire library of resources.

Unlock Full Article
RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Nov 16, 2026
Ep. 114 Anti-Aging Mini Mastermind Part 4
Preview only
Journal Club – Episode 114

In Part 4 of the Anti-Aging Mini Mastermind, Dr. Seeds explores how NAD synthesis, mitochondrial function, and cellular signaling influence immune function, inflammation, and aging through the lens of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Nov 12, 2026
FDA Requires New Safety Warnings for GLP-1 Receptor Agonists Due to Potential Vision Risk
BREAKING NEWS [NOVEMBER 12, 2026] – On November 9, the U.S. Food and Drug Administration (FDA) announced new safety labeling requirements for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), citing a potential increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition that can cause sudden, painless vision loss, sometimes permanently. The […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Nov 9, 2026
Ep. 113 - Dr. Seeds' Office Hours
Preview only
Dr. Seeds’ Office Hours – Episode 113

1. Dr. Seeds explores the clinical priorities in a 50-year-old female kidney transplant recipient with lupus, chronic steroid use, IBS, fatigue, and reported low morning glucose, focusing on metabolic function, gut health, and preserving immune tolerance. [0:47]

Preview Only — Become a member for full access
Promoitalia Nov 5, 2026
SSRP Institute Welcomes Promoitalia as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [November 5, 2026] — The SSRP Institute announces that Promoitalia has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Promoitalia is an Italian aesthetic medicine company that develops professional technologies, methodologies, and consumable products for regenerative aesthetics and skin health. Its work combines professional […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Nov 2, 2026
Ep. 112 - Peptide Therapy Gets a Smarter Upgrade
Preview only
Dissecting Protocols – Episode 112

Peptide Therapy Gets a Smarter Upgrade

Dr. Seeds addresses the often-overlooked challenges of peptide purity, patient adherence, and administration. He also shares the journey behind the Redox Smart Pen, highlighting years of collaboration with scientists, physicians, and formulators to help raise the standard for peptide therapy and advance the future of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Oct 29, 2026
Dr. Seeds and Medivive Announce the Redox Smart Pen: A Novel Technology for Precise Peptide Administration
BREAKING NEWS WILLOUGHBY, Ohio [October 29, 2026] — Dr. Seeds and Medivive announce the launch of the Redox Smart Pen, an innovative pre-filled autoinjector peptide delivery system designed to improve precision and consistency in physician-directed peptide protocols. Importantly, the Redox Smart Pen was developed through a proprietary methodology focused on uniform potency, accuracy of administration, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 26, 2026
Ep. 111 - Can BPC-157 & HBOT Prevent Amputation?
Preview only
Dissecting Protocols – Episode 111

Can BPC-157 & HBOT Prevent Amputation?

Dr. Seeds explores the potential and limitations of these investigational approaches, emphasizing the importance of blood flow, patient phenotyping, and cellular function in limb salvage. (Question Link)

Preview Only — Become a member for full access
PharmaNutra Oct 22, 2026
SSRP Institute Welcomes PharmaNutra as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [October 22, 2026] — The SSRP Institute announces that PharmaNutra has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Founded in Italy in 2003, PharmaNutra is a pharmaceutical and nutraceutical company focused on the research, development, and production of nutritional supplements and medical devices. […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 19, 2026
Ep. 110 - The Macrophage Mystery: Decoding Aging
Preview only
Rabbit Holes – Episode 110

The Macrophage Mystery: Decoding Aging

In Part 3 of our Anti-Aging Mini Mastermind, Dr. Seeds explores how aging alters PGE2/EP2 signaling, influencing macrophage metabolism, immune function, and inflammation, and examines potential therapeutic implications.
Articles referenced: (2026 Article) (2021 Article)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Aging Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.